ONDOT Drotaverine HCL, Mefenamic Acid TABLETS
Price 100 INR/ Box
ONDOT Drotaverine HCL, Mefenamic Acid TABLETS Specification
- Molecular Formula
- Drotaverine HCL: C24H31NO4HCl, Mefenamic Acid: C15H15NO2
- Appearance
- Film-coated tablets
- Assay
- Drotaverine HCL 80mg + Mefenamic Acid 250mg per tablet
- Dosage
- As directed by the physician
- Usage
- For treatment of spasmodic pain and dysmenorrhea
- Pacakaging (Quantity Per Box)
- 10 x 10 tablets per box
- Storage
- Store in a cool, dry, and dark place below 25C
- Dosage Form
- Tablet
- Grade
- Pharmaceutical Grade
- CAS No
- Drotaverine HCL: 985-12-6, Mefenamic Acid: 61-68-7
- Expiration Date
- 36 months from date of manufacture
- Salt Composition
- Drotaverine Hydrochloride 80mg, Mefenamic Acid 250mg
- Medicine Type
- Allopathic
- Indication
- Antispasmodic and analgesic, used in smooth muscle spasms, dysmenorrhea, and pain relief
- Origin of Medicine
- India
- Precautions
- Not recommended for patients with hypersensitivity to ingredients, gastrointestinal ulcers, or certain kidney/liver disorders
- Directions for Use
- Swallow whole with water, do not crush or chew
- Prescription/Non-Prescription
- Prescription
- Batch Number
- Available on package label
- Shape
- Oblong
- Side Effects
- Possible gastrointestinal irritation, nausea, dizziness, allergic reactions
- Administration Route
- Oral
- Color
- Yellow
ONDOT Drotaverine HCL, Mefenamic Acid TABLETS Trade Information
- Minimum Order Quantity
- 1000 Strips
- Payment Terms
- Cash in Advance (CID)
- Sample Available
- Yes
- Sample Policy
- Free samples are available
- Packaging Details
- 10X10
- Main Export Market(s)
- Asia
- Main Domestic Market
- All India
- Certifications
- GMP,ISO
About ONDOT Drotaverine HCL, Mefenamic Acid TABLETS
indications:
DROTAVERINE+MEFENAMIC ACID is a combination medicine used to treat abdominal pain, muscle pain, migraine headache, functional bowel disorders, dysmenorrhea (menstrual cramps), heavy bleeding during periods, renal colic pain, and pain after surgery.Targeted Relief for Spasmodic Pain
ONDOT Tablets are designed to provide fast and targeted relief from smooth muscle spasms and menstrual pain, combining Drotaverine HCL's muscle relaxant properties with Mefenamic Acid's effective analgesic action. This precise formulation helps address acute discomfort, making everyday activities more manageable for patients.
Strict Quality and Safety Standards
Manufactured under stringent pharmaceutical guidelines in India, ONDOT Tablets offer assurance of consistent potency and purity. Each batch is traceable via the package label, and the tablets meet exacting standards for safety and efficacy. They are suitable only for patients without certain hypersensitivities or pre-existing gastrointestinal, renal, or hepatic conditions.
Simple Oral Administration and Usage
These tablets are easy to take-simply swallow whole with water. Crushing or chewing is not recommended to maintain effectiveness and reduce gastrointestinal irritation. ONDOT tablets should only be used under a doctor's supervision, following prescribed dosage instructions for optimal results and safety.
FAQ's of ONDOT Drotaverine HCL, Mefenamic Acid TABLETS:
Q: How should ONDOT Drotaverine HCL, Mefenamic Acid Tablets be taken?
A: The tablets must be swallowed whole with water, without crushing or chewing. Always follow your physician's dosage instructions and do not exceed the prescribed amount.Q: What are the therapeutic uses of these tablets?
A: ONDOT Tablets are prescribed for relief from smooth muscle spasms and associated pain, such as that experienced in dysmenorrhea (menstrual pain) and other spasmodic conditions.Q: When should I avoid using these tablets?
A: These tablets should not be used if you have allergies to any ingredients, gastrointestinal ulcers, or certain kidney or liver disorders. Consult your doctor about your medical history before starting this medication.Q: Where should I store these tablets?
A: They must be kept in a cool, dry, and dark place below 25C, away from moisture and direct sunlight, to preserve their quality and effectiveness.Q: What side effects might occur during usage?
A: Possible side effects include gastrointestinal irritation, nausea, dizziness, and allergic reactions. Report any unexpected symptoms to your physician promptly.Q: How does this medicine benefit patients with spasmodic pain?
A: The combination of Drotaverine HCL and Mefenamic Acid provides both muscle relaxation and pain relief, offering rapid and significant improvement in spasmodic pain and menstrual discomfort.Q: What is the process for obtaining these tablets?
A: ONDOT Drotaverine HCL, Mefenamic Acid Tablets are available by prescription only. Discuss your symptoms with a licensed healthcare professional to determine if this medication is appropriate for you.
Price:
- 50
- 100
- 200
- 250
- 500
- 1000+
More Products in Antibiotic Medicine Category
RESTOL-650 TAB Paracetamol Tablets
Price 18.70 INR / Box
Minimum Order Quantity : 1000 Strips
Storage : Store in a cool, dry place, protected from light
Dosage : 650 mg
Medicine Type : Allopathic
Grade : Medicine Grade
RESPOVENT KID Montelukast Sodium & Levoctrizine di HCL Tablets
Price 70 INR / Box
Minimum Order Quantity : 1000 Strips
Storage : Store in a cool & dry place, below 30C, protect from light
Dosage : Montelukast Sodium 4 mg + Levocetirizine di HCL 2.5 mg
Medicine Type : Allopathic Tablets
Grade : Pharmaceutical Grade
Livosol Herbal liver Syrup
Price 150 INR / Bottle
Minimum Order Quantity : 1000 Bottles
Storage : Store in a cool, dry place away from direct sunlight
Dosage : 12 teaspoonfuls twice daily or as directed by physician
Medicine Type : Herbal Syrup
Grade : Therapeutic Grade
Jointheal Capsules
Price 195 INR / Box
Minimum Order Quantity : 1000 Vials
Storage : Store in cool, dry place away from direct sunlight
Dosage : One to two capsules twice daily or as directed by the physician
Medicine Type : Herbal Capsule
Grade : Pharmaceutical Grade
![]() |
BIOSEARCH ORGANICS
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |






Send Inquiry




